首页> 外国专利> Use of Apoptosis-Specific elF-5A siRNA to Down Regulate Expression of Proinflammatory Cytokines to Treat Sepsis

Use of Apoptosis-Specific elF-5A siRNA to Down Regulate Expression of Proinflammatory Cytokines to Treat Sepsis

机译:使用凋亡特异性elF-5A siRNA下调促炎细胞因子的表达以治疗脓毒症

摘要

The present invention relates to apoptosis specific eucaryotic initiation factor 5A (eIF-5A), referred to as apoptosis-specific eIF-5A or eIF5-A1, nucleic acids and polypeptides and methods for down regulating pro-inflammatory cytokines in a mammal by administering siRNA against eIF-5A1 to the mammal to treat/prevent sepsis and/or hemorrhagic shock.
机译:本发明涉及细胞凋亡特异性真核起始因子5A(eIF-5A),称为细胞凋亡特异性eIF-5A或eIF5-A1,核酸和多肽,以及通过施用siRNA而下调哺乳动物中促炎细胞因子的方法抗eIF-5A1的哺乳动物,以治疗/预防败血症和/或失血性休克。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号